Defunct Company
Total Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
789
NCT01111175
Triple Negative Breast Cancer Biomarker Study
Phase: N/A
Role: Collaborator
Start: May 31, 2010
Completion: Jun 30, 2013
NCT01285427
Clinical Protocol SeCore, uTYPE and 3500 Dx System
Role: Lead Sponsor
Start: Jan 31, 2011
Completion: Jun 30, 2011
NCT04332003
Evaluating Remote Ischemic Conditioning (RIC) and Standard of Care vs. Sham Therapy and Standard Care
Start: Jan 1, 2021
Completion: Feb 6, 2021
NCT05858294
The Safety, Acceptability and Efficacy of Alena
Start: Oct 31, 2022
Completion: Dec 18, 2022
NCT05987969
Efficacy and Safety of the Alena App as a Treatment for Social Anxiety Disorder
Start: Mar 20, 2023
Completion: Jun 7, 2023
NCT06343714
A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects
Phase: Phase 1
Start: Apr 7, 2024
Completion: May 30, 2026
NCT06506305
Clinical Study of FB1001 in Patients
Start: Aug 15, 2024
Completion: Oct 31, 2026